Suppr超能文献

推荐的工具化合物:靶向BET溴结构域的噻吩并三唑二氮杂卓衍生化学探针。

Recommended Tool Compounds: Thienotriazolodiazepines-Derivatized Chemical Probes to Target BET Bromodomains.

作者信息

Huang Chuhui, Harris Kate S, Siddiqui Ghizal, Jörg Manuela

机构信息

Medicinal Chemistry, Monash Institute of Pharmaceutical Science, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.

Drug Delivery, Disposition & Dynamics, Monash Institute of Pharmaceutical Science, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.

出版信息

ACS Pharmacol Transl Sci. 2025 Mar 14;8(4):978-1012. doi: 10.1021/acsptsci.4c00726. eCollection 2025 Apr 11.

Abstract

Thienotriazolodiazepines, including (+)-JQ1 (), are well-known inhibitors of the bromodomain (BD) and extra-terminal domain (BET) family of proteins. Despite the suboptimal physicochemical properties as a drug candidate, such as poor solubility and half-life, (+)-JQ1 () has proven as an effective chemical probe with high target potency and selectivity. (+)-JQ1 () and (+)-JQ1-derived chemical probes have played a vital role in chemical biology and drug discovery over the past decade, which is demonstrated by the high number of impactful research studies published since the disclosure of (+)-JQ1 ( in 2010. In this review, we discuss the development of (+)-JQ1-derivatized chemical probes over the past decade and their significant contribution to scientific research. Specifically, we will summarize the development of innovative label-free and labeled (+)-JQ1-derivatized chemical probes, such as bivalent, covalent, and photoaffinity probes as well as protein degraders, with a focus on the design of these chemical probes.

摘要

噻吩并三唑二氮杂卓类化合物,包括(+)-JQ1(),是众所周知的蛋白质溴结构域(BD)和额外末端结构域(BET)家族的抑制剂。尽管作为候选药物的物理化学性质欠佳,如溶解度和半衰期较差,但(+)-JQ1()已被证明是一种具有高靶点效力和选择性的有效化学探针。在过去十年中,(+)-JQ1()和源自(+)-JQ1的化学探针在化学生物学和药物发现中发挥了至关重要的作用,自2010年(+)-JQ1披露以来发表的大量有影响力的研究证明了这一点。在这篇综述中,我们讨论了过去十年中(+)-JQ1衍生化学探针的发展及其对科学研究的重大贡献。具体而言,我们将总结创新的无标记和标记的(+)-JQ1衍生化学探针的发展,如二价、共价和光亲和探针以及蛋白质降解剂,重点是这些化学探针的设计。

相似文献

1
Recommended Tool Compounds: Thienotriazolodiazepines-Derivatized Chemical Probes to Target BET Bromodomains.
ACS Pharmacol Transl Sci. 2025 Mar 14;8(4):978-1012. doi: 10.1021/acsptsci.4c00726. eCollection 2025 Apr 11.
2
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.
J Psychiatr Ment Health Nurs. 2024 Aug;31(4):681-698. doi: 10.1111/jpm.13023. Epub 2024 Jan 17.
8
Decoding the Penicillin-Binding Proteins with Activity-Based Probes.
Acc Chem Res. 2025 Jun 3;58(11):1754-1763. doi: 10.1021/acs.accounts.5c00113. Epub 2025 May 21.
9
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
10
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.

引用本文的文献

1
Methods to accelerate PROTAC drug discovery.
Biochem J. 2025 Jun 25;482(13):BCJ20243018. doi: 10.1042/BCJ20243018.

本文引用的文献

1
Leveraging Dual-Ligase Recruitment to Enhance Protein Degradation via a Heterotrivalent Proteolysis Targeting Chimera.
J Am Chem Soc. 2024 Dec 11;146(49):33675-33711. doi: 10.1021/jacs.4c11556. Epub 2024 Nov 28.
2
Principles of paralog-specific targeted protein degradation engaging the C-degron E3 KLHDC2.
Nat Commun. 2024 Oct 12;15(1):8829. doi: 10.1038/s41467-024-52966-3.
3
Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy.
Bioorg Med Chem. 2024 Oct 1;112:117875. doi: 10.1016/j.bmc.2024.117875. Epub 2024 Aug 16.
4
Regulated induced proximity targeting chimeras-RIPTACs-A heterobifunctional small molecule strategy for cancer selective therapies.
Cell Chem Biol. 2024 Aug 15;31(8):1490-1502.e42. doi: 10.1016/j.chembiol.2024.07.005. Epub 2024 Aug 7.
5
Modular Development of Enzyme-Activatable Proteolysis Targeting Chimeras for Selective Protein Degradation and Cancer Targeting.
JACS Au. 2024 May 16;4(7):2564-2577. doi: 10.1021/jacsau.4c00298. eCollection 2024 Jul 22.
6
Protocol for the comprehensive biochemical and cellular profiling of small-molecule degraders using CoraFluor TR-FRET technology.
STAR Protoc. 2024 Jun 21;5(2):103129. doi: 10.1016/j.xpro.2024.103129. Epub 2024 Jun 9.
7
Click Chemistry: Reaction Rates and Their Suitability for Biomedical Applications.
Bioconjug Chem. 2024 Jun 19;35(6):715-731. doi: 10.1021/acs.bioconjchem.4c00084. Epub 2024 May 22.
8
Alkenyl oxindole is a novel PROTAC moiety that recruits the CRL4DCAF11 E3 ubiquitin ligase complex for targeted protein degradation.
PLoS Biol. 2024 May 20;22(5):e3002550. doi: 10.1371/journal.pbio.3002550. eCollection 2024 May.
9
Discovery of potent and novel dual NAMPT/BRD4 inhibitors for efficient treatment of hepatocellular carcinoma.
Eur J Med Chem. 2024 May 5;271:116444. doi: 10.1016/j.ejmech.2024.116444. Epub 2024 Apr 26.
10
Current advances in photocatalytic proximity labeling.
Cell Chem Biol. 2024 Jun 20;31(6):1145-1161. doi: 10.1016/j.chembiol.2024.03.012. Epub 2024 Apr 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验